


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.39%
+24.05%
+1.04%
-8.58%
+2.33%
BDX
Becton, Dickinson and
$176.56
Strengths

Earnings are forecast to grow

Investors confidence is positive
Chart
$186.59 (-5.38%)
$195.96 (-9.90%)
$172.1 (+2.59%)
$222.64 (-20.70%)
BDX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

BDX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
BDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BDX Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayBDX Earnings
The TTM reflects 12-month period, providing review of BDX financial performance.
The company financial health has moderately improved over the past year
Financial Score
BSX
98.89
-0.04%
TFX
110.07
-11.73%
RMD
249.51
+1.62%
IRTC
177.56
-2.02%
What is BDX current stock price?
What are BDX stock strengths?
What risks are associated with BDX stock?
When is BDX next earnings report?
What is BDX market cap and volume?
What is BDX's current Stock IQ?
Should I buy BDX stock right now?
Is BDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BDX?
What does a 'Strong Sell' rating mean for BDX?
What factors influence BDX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.39%
+24.05%
+1.04%
-8.58%
+2.33%
BDX
Becton, Dickinson and
Current Price
$176.56
Stock Insights
Strengths

Earnings are forecast to grow

Investors confidence is positive
Linked to BDX
BSX
98.89
-0.04%
TFX
110.07
-11.73%
RMD
249.51
+1.62%
IRTC
177.56
-2.02%

Chart
$186.59 (-5.38%)
$195.96 (-9.90%)
$172.1 (+2.59%)
$222.64 (-20.70%)
BDX Analysts Opinion
BDX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
BDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BDX Street view is extremely bullish and have positive views on the near-term outlook
BDX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
BDX Earnings
The TTM data reflects the most recent 12-month period, providing overview of BDX financial performance.
BDX Financial Health
The company financial health has moderately improved over the past year
Financial Score
BDX Latest Analysis
Becton Dickinson And Company Q4 Profit Increases Beats Estimates . (RTTNews) - Becton Dickinson and Company (BDX) reported a profit for its fourth quarter that Increased from last year and beat the Street estimates.
Today
Becton Dickinson Guides FY26 Adj. EPS In Line With Estimates - Update . (RTTNews) - While reporting financial results for the fourth quarter on Thursday medical technology company Becton Dickinson and Co. (BDX) initiated its adjusted earnings and revenue growth guidance for the full-year 2026.
Today
Becton Dickinson declares $1.05 dividend.
Today
Becton Dickinson reports mixed Q4 results. initiates FY26 outlook.
Today
BD Receives United States FDA EU Clearance For Enteric Bacterial Panels On BD COR System . (RTTNews) - Becton Dickinson and Company (BDX) a medical technology firm on Monday said it has received United States Food and Drug Administration (FDA) 510(k) clearance and Conformité. Europé.enne (CE) marking in the European Union for its Enteric Bacterial Panel (EBP) and Enteric Bacte
Mon Nov 3, 2025
Heres Why Becton Dickinson (BDX) is a Strong Growth Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.
Thu Oct 23, 2025
RBC Capital Reiterates Becton Dickinson and (BDX) Sector Perform Recommendation. Fintel reports that on October 16 2025 RBC Capital reiterated coverage of Becton Dickinson and (NYSE:BDX) with a Sector Perform recommendation. Analyst Price Forecast Suggests 19.70% Upside
Fri Oct 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.